I don`t believe my distain for the GRAS is misplaced, to make publication of safety data a condition is a cop out and achieves what. What about the 1000 or so trial participants that suffered no side effects. The GRAS process probably started 18mths ago and still isn`t complete, that is a real cost in terms of value lost in sales and patent life.
CZD Price at posting:
4.6¢ Sentiment: Buy Disclosure: Held